[{"address1": "2450 Holcombe Blvd", "address2": "MS: BCM251", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "713 400 6400", "website": "https://markertherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Juan F. Vera M.D.", "age": 44, "title": "Co-Founder, CEO, President, Treasurer, Secretary & Director", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 400000, "exercisedValue": 0, "unexercisedValue": 9390}, {"maxAge": 1, "name": "Ms. Elizabeth  Donnelly", "title": "Director of Administration", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Maria-Bernadette  Madel Ph.D.", "age": 34, "title": "Director of Corporate Operations & External Communications", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Cheung", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Patricia  Allison", "title": "Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary  Newman Ph.D.", "age": 65, "title": "Head of Regulatory Affairs", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Z. Florkiewicz Sr., Ph.D.", "title": "Senior Director of Molecular Biology & Virology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.26, "open": 1.29, "dayLow": 1.25, "dayHigh": 1.2997, "regularMarketPreviousClose": 1.26, "regularMarketOpen": 1.29, "regularMarketDayLow": 1.25, "regularMarketDayHigh": 1.2997, "payoutRatio": 0.0, "beta": 1.35, "forwardPE": -1.6202531, "volume": 232722, "regularMarketVolume": 232722, "averageVolume": 274504, "averageVolume10days": 313530, "averageDailyVolume10Day": 313530, "bid": 1.3, "ask": 1.65, "bidSize": 1, "askSize": 2, "marketCap": 16561804, "fiftyTwoWeekLow": 0.81, "fiftyTwoWeekHigh": 4.07, "allTimeHigh": 6120000.0, "allTimeLow": 0.67, "priceToSalesTrailing12Months": 3.5275497, "fiftyDayAverage": 1.1066, "twoHundredDayAverage": 1.2156, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3751624, "profitMargins": 0.0, "floatShares": 13676466, "sharesOutstanding": 12938910, "sharesShort": 233661, "sharesShortPriorMonth": 251271, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.0139999995, "heldPercentInsiders": 0.05493, "heldPercentInstitutions": 0.20703, "shortRatio": 0.94, "shortPercentOfFloat": 0.034, "impliedSharesOutstanding": 12938910, "bookValue": 1.103, "priceToBook": 1.1604713, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -14298034, "trailingEps": -1.17, "forwardEps": -0.79, "lastSplitFactor": "1:10", "lastSplitDate": 1674777600, "enterpriseToRevenue": 0.799, "52WeekChange": -0.625731, "SandP52WeekChange": 0.14402747, "quoteType": "EQUITY", "currentPrice": 1.28, "targetHighPrice": 10.0, "targetLowPrice": 4.0, "targetMeanPrice": 7.33333, "targetMedianPrice": 8.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 17589978, "totalCashPerShare": 1.055, "totalDebt": 0, "quickRatio": 5.755, "currentRatio": 6.496, "totalRevenue": 4694988, "revenuePerShare": 0.368, "returnOnAssets": -0.55195, "returnOnEquity": -1.10672, "grossProfits": -9066857, "freeCashflow": -10881111, "operatingCashflow": -14817110, "revenueGrowth": -0.36, "grossMargins": -1.93118, "ebitdaMargins": 0.0, "operatingMargins": -1.73304, "financialCurrency": "USD", "symbol": "MRKR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.5873, "regularMarketPrice": 1.28, "cryptoTradeable": false, "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_1725474", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Marker Therapeutics, Inc.", "longName": "Marker Therapeutics, Inc.", "postMarketChangePercent": 3.1250064, "postMarketPrice": 1.32, "postMarketChange": 0.04000008, "regularMarketChange": 0.02, "regularMarketDayRange": "1.25 - 1.2997", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 274504, "fiftyTwoWeekLowChange": 0.46999997, "fiftyTwoWeekLowChangePercent": 0.58024687, "fiftyTwoWeekRange": "0.81 - 4.07", "fiftyTwoWeekHighChange": -2.7900002, "fiftyTwoWeekHighChangePercent": -0.6855037, "fiftyTwoWeekChangePercent": -62.573097, "dividendDate": 1473984000, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.17, "epsForward": -0.79, "epsCurrentYear": -0.935, "priceEpsCurrentYear": -1.3689839, "fiftyDayAverageChange": 0.17339993, "fiftyDayAverageChangePercent": 0.15669611, "twoHundredDayAverageChange": 0.06439996, "twoHundredDayAverageChangePercent": 0.05297792, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1026826200000, "corporateActions": [], "postMarketTime": 1766192362, "regularMarketTime": 1766178002, "displayName": "Marker Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]